Cargando…
Anandamide in the dorsal periaqueductal gray inhibits sensory input without a correlation to sympathoexcitation
There is growing literature supporting cannabinoids as a potential therapeutic for pain conditions. The development of chronic pain has been associated with reduced concentrations of the endogenous cannabinoid anandamide (AEA) in the midbrain dorsal periaqueductal gray (dPAG), and microinjections of...
Autores principales: | Roberts, Christopher J., Hopp, Francis A., Hogan, Quinn H., Dean, Caron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755024/ https://www.ncbi.nlm.nih.gov/pubmed/36531614 http://dx.doi.org/10.1016/j.ynpai.2022.100104 |
Ejemplares similares
-
Blockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the Antinociceptive Effect of Local Injections of Anandamide in Mice
por: Mascarenhas, Diego C., et al.
Publicado: (2017) -
Dorsal periaqueductal gray ensembles represent approach and avoidance states
por: Reis, Fernando MCV, et al.
Publicado: (2021) -
Neural Correlates of Fear in the Periaqueductal Gray
por: Watson, Thomas C., et al.
Publicado: (2016) -
Cerebellar modulation of synaptic input to freezing-related neurons in the periaqueductal gray
por: Vaaga, Christopher E, et al.
Publicado: (2020) -
Fine-tuning of defensive behaviors in the dorsal periaqueductal gray by atypical neurotransmitters
por: Fogaça, M.V., et al.
Publicado: (2012)